VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,911 | +0.2% | 2,784 | +12.1% | 0.02% | +4.5% |
| Q2 2023 | $74,786 | +3.6% | 2,484 | +11.3% | 0.02% | -4.3% |
| Q1 2023 | $72,221 | +12.9% | 2,232 | 0.0% | 0.02% | -4.2% |
| Q4 2022 | $63,983 | +36.1% | 2,232 | +14.2% | 0.02% | +26.3% |
| Q3 2022 | $47,000 | -25.4% | 1,954 | +18.1% | 0.02% | -13.6% |
| Q1 2022 | $63,000 | +18.9% | 1,654 | 0.0% | 0.02% | +15.8% |
| Q4 2021 | $53,000 | +26.2% | 1,654 | +15.7% | 0.02% | +11.8% |
| Q3 2021 | $42,000 | +50.0% | 1,429 | +17.0% | 0.02% | -19.0% |
| Q1 2020 | $28,000 | -22.2% | 1,221 | 0.0% | 0.02% | -19.2% |
| Q4 2019 | $36,000 | – | 1,221 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |